These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 26753210)
21. Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force. Smith EMD; Aggarwal A; Ainsworth J; Al-Abadi E; Avcin T; Bortey L; Burnham J; Ciurtin C; Hedrich CM; Kamphuis S; Levy DM; Lewandowski LB; Maxwell N; Morand EF; Ozen S; Pain CE; Ravelli A; Saad Magalhaes C; Pilkington CA; Schonenberg-Meinema D; Scott C; Tullus K; Beresford MW; Ann Rheum Dis; 2023 Jun; 82(6):788-798. PubMed ID: 36627168 [TBL] [Abstract][Full Text] [Related]
22. Recent advances in rheumatology: biological agents for the treatment of rheumatoid arthritis, the progression of psoriatic arthritis, autoantibodies in systemic lupus erythematosus. Finucane KA; Archer CB Clin Exp Dermatol; 2005 Mar; 30(2):201-4. PubMed ID: 15725261 [No Abstract] [Full Text] [Related]
23. Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Gottenberg JE; Guillevin L; Lambotte O; Combe B; Allanore Y; Cantagrel A; Larroche C; Soubrier M; Bouillet L; Dougados M; Fain O; Farge D; Kyndt X; Lortholary O; Masson C; Moura B; Remy P; Thomas T; Wendling D; Anaya JM; Sibilia J; Mariette X; Ann Rheum Dis; 2005 Jun; 64(6):913-20. PubMed ID: 15550531 [TBL] [Abstract][Full Text] [Related]
24. [Treat to target in systemic lupus erythematosus]. Mucke J; Düsing C; Chehab G; Schneider M Z Rheumatol; 2020 May; 79(4):351-358. PubMed ID: 32232548 [TBL] [Abstract][Full Text] [Related]
25. Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019. Winthrop KL; Weinblatt ME; Bathon J; Burmester GR; Mease PJ; Crofford L; Bykerk V; Dougados M; Rosenbaum JT; Mariette X; Sieper J; Melchers F; Cronstein BN; Breedveld FC; Kalden J; Smolen JS; Furst D Ann Rheum Dis; 2020 Jan; 79(1):88-93. PubMed ID: 31662322 [TBL] [Abstract][Full Text] [Related]
26. [Therapy of inflammatory rheumatic diseases: from current practice standards to future]. Gause A; Manger B; Kalden JR; Burmester GR Internist (Berl); 2001 Feb; 42(2):223-32, 234-6. PubMed ID: 11244877 [No Abstract] [Full Text] [Related]
27. [Pharmacotherapy in pregnancy and lactation in rheumatic diseases]. Anić B; Cikes N Reumatizam; 2006; 53(2):55-8. PubMed ID: 17580555 [TBL] [Abstract][Full Text] [Related]
28. The unmet need in rheumatology: reports from the Targeted Therapies meeting 2016. Winthrop KL; Strand V; van der Heijde DM; Mease PJ; Crow MK; Weinblatt M; Bathon JM; Buch MH; Burmester GR; Dougados M; Kay J; Mariette X; Breedveld FC; Kalden JR; Smolen JS; Furst DE Clin Exp Rheumatol; 2016; 34(4 Suppl 98):69-76. PubMed ID: 27586809 [TBL] [Abstract][Full Text] [Related]
29. Obstacles to the implementation of the treat-to-target strategy for rheumatoid arthritis in clinical practice in Japan. Kaneko Y; Koike T; Oda H; Yamamoto K; Miyasaka N; Harigai M; Yamanaka H; Ishiguro N; Tanaka Y; Takeuchi T Mod Rheumatol; 2015 Jan; 25(1):43-9. PubMed ID: 24950169 [TBL] [Abstract][Full Text] [Related]
30. Pharmacogenetics in the rheumatic diseases. Cronstein BN Bull NYU Hosp Jt Dis; 2006; 64(1-2):16-9. PubMed ID: 17121484 [TBL] [Abstract][Full Text] [Related]
31. [Pharmacological management of inflammatory rheumatic conditions]. Bannwarth B Therapie; 2011; 66(5):377-81. PubMed ID: 22031680 [TBL] [Abstract][Full Text] [Related]